Eukedos S.p.A. (EUK) AI Stock Analysis

• Market Cap: €15.92M
• Dividend Yield: N/A
• Average Volume (3M): 4.68K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.07
• Revenue Growth: 4.81%
• EPS Growth: -260.95%
• Country: IT
• Employees: 483
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): N/A
• Shares Outstanding: 22,741,629
• 10 Day Avg. Volume: 3,064
• 30 Day Avg. Volume: 4,678
• PEG Ratio: 0.18
• Price to Book (P/B): 0.62
• Price to Sales (P/S): 0.36
• P/FCF Ratio: -1.40
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.05
• Revenue Forecast (FY): €52.40M

• Rating: 54 Neutral
• Price Target: €1.00 ▲(42.86% Upside)

Eukedos S.p.A. shows strong operational efficiency, but financial risks due to high leverage and cash flow issues are significant concerns. Technical indicators suggest a stable outlook, but valuation metrics are unfavorable due to negative profitability. The absence of earnings call data and corporate events limits further insights.

Positive Factors

Operational Efficiency

High gross profit and EBITDA margins indicate effective cost management and operational efficiency, supporting long-term profitability.

Diverse Revenue Streams

Diverse revenue streams from software, subscriptions, and hardware sales reduce dependency on a single source, enhancing stability.

Strategic Partnerships

Partnerships with industry leaders expand product offerings and market reach, fostering growth and competitive advantage.

Negative Factors

High Leverage

Significant leverage could pose financial risks by increasing interest obligations and reducing financial flexibility.

Negative Free Cash Flow

Negative free cash flow suggests challenges in generating cash from operations, potentially impacting liquidity and investment capacity.

Negative Profitability

Negative net profit margin reflects difficulties in converting revenue into profit, potentially affecting long-term financial health.

Eukedos S.p.A. Business Overview & Revenue Model

Company Description

EuKedos S.p.A. provides managed and long-term care services in Italy. The company offers residential social care services to elderly, self-sufficient, or incapacitated adults. It manages healthcare and assistance residences with 1,345 beds in the North and Central Italy, primarily located in Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is based in Florence, Italy.

How the Company Makes Money

Eukedos generates revenue primarily through the sale of its biochemical products across multiple sectors. The company's revenue model is based on direct sales to businesses in the pharmaceutical and agricultural industries, as well as partnerships with distributors who extend its market reach. Key revenue streams include product sales, licensing agreements for proprietary technologies, and partnerships with research institutions that fund collaborative projects. Additionally, Eukedos benefits from government grants and funding aimed at promoting sustainable agricultural practices and environmental conservation, which contribute to its overall earnings.

Eukedos S.p.A. Financial Statement Overview

Summary

Eukedos S.p.A. demonstrates strong operational efficiency with high gross profit and EBITDA margins. However, the company faces challenges with profitability and high leverage, which could impact financial stability. Cash flow issues, particularly negative free cash flow, indicate potential liquidity concerns.

Income Statement

Eukedos S.p.A. shows a strong gross profit margin of 94.71% for 2024, indicating efficient cost management. However, the net profit margin is negative at -1.01%, reflecting challenges in converting revenue into profit. Revenue growth is modest at 1.96%, suggesting stable but slow expansion. The EBIT and EBITDA margins are healthy at 10.10% and 23.74%, respectively, showing operational efficiency.

Balance Sheet

The company has a high debt-to-equity ratio of 3.32, indicating significant leverage, which could pose financial risks. Return on equity is negative at -1.76%, suggesting inefficiencies in generating returns for shareholders. The equity ratio is not provided, but the high leverage suggests limited equity relative to assets.

Cash Flow

Operating cash flow is positive, but free cash flow is negative, indicating potential liquidity issues. The free cash flow to net income ratio is -1.32, highlighting challenges in generating cash from operations. The operating cash flow to net income ratio of 0.34 suggests moderate cash generation efficiency.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	52.60M	51.69M	49.45M	47.04M	45.18M	46.99M
Gross Profit	13.25M	48.96M	13.73M	32.03M	32.99M	33.77M
EBITDA	7.95M	12.27M	12.41M	10.87M	10.72M	7.63M
Net Income	-1.15M	-524.00K	556.00K	443.00K	570.00K	-1.92M
Balance Sheet
Total Assets	178.40M	179.34M	149.10M	153.38M	150.08M	146.26M
Cash, Cash Equivalents and Short-Term Investments	2.68M	3.91M	2.33M	3.62M	7.39M	2.64M
Total Debt	124.82M	99.02M	105.83M	111.45M	108.95M	102.89M
Total Liabilities	149.35M	149.50M	119.19M	123.99M	121.26M	118.02M
Stockholders Equity	29.05M	29.84M	29.91M	29.39M	28.82M	28.25M
Cash Flow
Free Cash Flow	-15.15M	-13.14M	3.59M	1.03M	5.31M	1.27M
Operating Cash Flow	5.81M	9.94M	10.08M	5.18M	5.61M	6.68M
Investing Cash Flow	-50.70M	-58.49M	-8.92M	-4.15M	-306.00K	-5.31M
Financing Cash Flow	42.76M	50.13M	-2.45M	-4.79M	-562.00K	-1.71M

Eukedos S.p.A. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.70
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:EUK, the sentiment is Negative. The current price of 0.7 is below the 20-day moving average (MA) of 0.71, below the 50-day MA of 0.73, and below the 200-day MA of 0.76, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 41.37 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:EUK.

Eukedos S.p.A. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EUK	54 Neutral	€15.92M	-13.81	―	―	4.81%	-260.95%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Eukedos S.p.A. Corporate Events

Eukedos S.p.A. Aligns 2024 Sustainability Report with EU Taxonomy

Eukedos S.p.A. has clarified its 2024 Sustainability Report in line with EU Taxonomy regulations, which classify eco-sustainable economic activities. The company identified its residential care services and energy efficiency projects as eligible activities under these regulations, although these activities have a marginal impact on revenue, operating, and capital expenditures.

Eukedos S.p.A. Announces 2026 Corporate Event Calendar

Eukedos S.p.A. has announced its corporate event calendar for 2026, highlighting key dates for financial disclosures and shareholder meetings. This schedule outlines the company’s commitment to transparency and regular communication with stakeholders, potentially impacting investor relations and market perceptions.

Eukedos S.p.A. Reports Mixed Half-Year Financial Results for 2025

Eukedos S.p.A. reported its half-year financial results for 2025, showing a slight increase in consolidated production value to €25.8 million compared to the previous year. However, the company experienced a decrease in EBITDA and reported a larger group loss, indicating financial challenges despite a slight improvement in occupancy rates within its care services. The net financial position remains negative, heavily influenced by lease accounting standards, which may impact future financial strategies.